The Dales Report: Ketamine expert Dr. Robison on clinical trials, ketamine for eating disorders, and Novamind’s plans for growth

It was a privilege to sit down with Amanda Siebert of The Dales Report take a look at the how ketamine is being studied and used to treat psychiatric conditions. I explain my background with this drug, starting back in 2011, and talk about our current programs centered around ketamine-assisted psychotherapy. I also spend some time explaining the psychedelic clinical trials process and how we’re involved with these kinds of studies at Novamind. Feel free to watch the full interview or read Amanda’s summary—both found at the link below.